ArticleRadiology case reports2025
Percutaneous radiofrequency ablation of pancreatic insulinoma: A case report and literature review.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Insulinomas are functional neuroendocrine neoplasms arising from the pancreatic islet cells resulting in excess insulin secretion and hypoglycemic episodes. Surgical resection is the standard treatment, but minimally invasive options such as radiofrequency ablation (RFA) have emerged as valuable alternatives, especially for nonsurgical candidates. We present the case of a 38-year-old male experiencing repeated episodes of critical hypoglycemia secondary to a pancreatic insulinoma, confirmed by elevated insulin and C-peptide levels and imaging findings. Initial surgical resection was unsuccessful due to intraoperative difficulty in localizing the lesion. The patient was subsequently treated with percutaneous RFA. Following the procedure, he developed mild pancreatitis, which was managed conservatively with complete resolution Follow-up at 12 months showed significant clinical improvement, normalization of insulin levels, and no evidence of tumor recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.